Clofazimine

CAS 2030-63-9 6 current records 1 historicalSmall Molecule

Who holds supplier records for Clofazimine? 6 organisations hold a current record for Clofazimine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Germany (1), China (1) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clofazimine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clofazimine

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clofazimine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Clofazimine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Clofazimine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MIDAS PHARMA GMBH Ingelheim am RheinDE
CEP 2019-257 - Rev 02
Clofazimine, Triclinic form
Jun 2025Inspected Apr 2026
Germany
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2024-201 - Rev 00
Clofazimine
Dec 2024—
ARENE LIFE SCIENCES PRIVATE LIMITED SangareddyIN
R0-CEP 2023-008 - Rev 00
Clofazimine
Aug 2023—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2016-291 - Rev 00
Clofazimine
Jan 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Clofazimine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • SANGROSE LABORATORIES PVT LTD
    Inactive DMF 25326 · filed Sept 2011

Overview

Clofazimine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1292).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antimycobacterial

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clofazimine?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Clofazimine: HARMAN FINOCHEM LTD (India), MIDAS PHARMA GMBH (Germany), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), OLON SPA (Italy), SANDOZ PRIVATE LTD (India) and Arene Life Sciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clofazimine Drug Master Files are active?

HARMAN FINOCHEM LTD (DMF 39972), MIDAS PHARMA GMBH (DMF 34254), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 31256), OLON SPA (DMF 33157) and SANDOZ PRIVATE LTD (DMF 16668). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clofazimine records mean?

1 organisation has only inactive Type II DMFs for Clofazimine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Clofazimine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Clofazimine on the EDQM register, including MIDAS PHARMA GMBH Ingelheim am Rhein (DE), HARMAN FINOCHEM LIMITED Mumbai (IN), ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy (IN) and ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Clofazimine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clofazimine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.